Kirchdorf, Germany

Franz Riener

This inventor holds 1 USPTO granted patent. Top assignee: Wacker-Chemie Gmbh. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franz Riener: Innovator in Methylsilanes Chlorination

Introduction

Franz Riener is a notable inventor based in Kirchdorf, Germany. He has made significant contributions to the field of chemical engineering, particularly in the chlorination of methylsilanes. His innovative approach has led to advancements in industrial processes.

Latest Patents

Franz Riener holds a patent for a process for the chlorination of methylsilanes. This invention involves reacting methylsilanes with chlorine in the presence of at least 0.1% by weight of hydrogen chloride. The process is conducted under electromagnetic radiation, which facilitates chlorination while using chlorine in a substoichiometric amount. The reaction occurs at temperatures below the boiling point of the methylsilane, making it efficient for industrial applications.

Career Highlights

Riener is associated with Wacker-Chemie GmbH, a leading company in the chemical industry. His work has been instrumental in enhancing the efficiency of chemical processes, particularly in the production of silanes. His innovative methods have contributed to the company's reputation for excellence in chemical manufacturing.

Collaborations

Franz Riener has collaborated with esteemed colleagues such as Helmut Hollfelder and Siegfried Pflaum. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Franz Riener is a distinguished inventor whose work in the chlorination of methylsilanes has made a significant impact on the chemical industry. His contributions continue to influence modern chemical processes and enhance industrial efficiency.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…